OFFICIAL PUBLICATION OF

by its subsidiary APPco

Price reduction for combinations

Chris Brooker 02/08/2016

A range of combination medicines are due to experience price cuts in the 1 October round of price disclosure measures.The newly advised cuts will affect combination drugs due to experience flow-on price reductions.The 2015 Access and Sustainability amendments to the National Health Act 1953 provide for price disclosure reductions to component drugs to be flowed-on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

Price reduction for combinations

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.